James Loerop

Insider Reports History

Location
Wayne, PA
Signature
/s/ Matthew Rothman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James Loerop:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aclaris Therapeutics, Inc. Chief Business Officer Common Stock 155,041 $446,518 $2.88 02 Jan 2026 Direct
Aclaris Therapeutics, Inc. Chief Business Officer Restricted Stock Units 18,700 $207,080 $2.48 02 Jan 2026 Direct
Anika Therapeutics, Inc. EVP Business Development Common Stock 5,592 $104,179 $18.63 08 Jul 2021 Direct
Anika Therapeutics, Inc. EVP Business Development Restricted Stock Unit 3,000 $77,370 $25.79 08 Jul 2021 Direct
Aclaris Therapeutics, Inc. Chief Business Officer Employee Stock Option (Right to Buy) 292,300 03 Feb 2025 Direct
Aclaris Therapeutics, Inc. Chief Business Officer Resticted Stock Units 15,000 01 Feb 2025 Direct

Insider Reports Filed by James Loerop

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ACRS Aclaris Therapeutics, Inc. 31 Dec 2025 6 -$120,094 4 Chief Business Officer 05 Jan 2026, 16:30
ACRS Aclaris Therapeutics, Inc. 01 Feb 2025 9 -$38,309 4 Chief Business Officer 04 Feb 2025, 16:15
ACRS Aclaris Therapeutics, Inc. 31 Dec 2024 7 -$100,847 4 Chief Business Officer 03 Jan 2025, 18:25
ACRS Aclaris Therapeutics, Inc. 01 Feb 2024 9 -$7,705 4 Chief Business Officer 05 Feb 2024, 19:29
ACRS Aclaris Therapeutics, Inc. 28 Aug 2023 1 +$99,959 4 Chief Business Officer 28 Aug 2023, 16:39
ACRS Aclaris Therapeutics, Inc. 08 Feb 2023 1 -$59,272 4 Chief Business Officer 10 Feb 2023, 15:55
ACRS Aclaris Therapeutics, Inc. 01 Feb 2023 4 $0 4 Chief Business Officer 03 Feb 2023, 16:01
ACRS Aclaris Therapeutics, Inc. 01 Feb 2022 2 $0 4 Chief Business Officer 01 Feb 2022, 15:50
ACRS Aclaris Therapeutics, Inc. 31 Jan 2022 0 $0 3 Chief Business Officer 01 Feb 2022, 15:45
ANIK Anika Therapeutics, Inc. 08 Jul 2021 3 -$31,608 4 EVP Business Development 12 Jul 2021, 16:15